Chapters

Transcript

Video

Impact of Angiotensin Blockade on Response to PD1/L1 Inhibitors for Patients with Metastatic Urothelial Carcinoma (mUC)

Bladder cancer research presented by Dana-Farber's Guru Sonpavde, MD at ASCO #GU21: Impact of angiotensin blockade on response to PD1/L1 inhibitors for patients with metastatic urothelial carcinoma (mUC) Abstract 453


Published

February 19, 2021

Created by

Dana-Farber

Related Presenters

Guru P. Sonpavde, MD

Guru P. Sonpavde, MD

Medical Oncology

Guru P. Sonpavde, MD is the Bladder Cancer Director at Dana Farber Cancer Institute.

View full Profile